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Abstract
The controversial introduction of rbST, a laboratory version of bST, a growth hormone that stimulates
milk production in cows, may provide hopeful lessons for other foods produced by biotechnology.
Milk sales remained steady after rbST became available to dairy farmers, even though a multitude of
public opinion surveys documented widespread concern about food safety and biotechnology, and
some analysts predicted a drop in milk consumption of up to 20 percent. The undiminished consumer
demand for milk may indicate that consumers will also accept other animal food products from
biotechnology. The rbST experience suggests that, while scientific evidence of food safety will not
prevent controversy over biotech foods, controversy will not necessarily inhibit consumer demand for
the food.
Introduction
Potential consumer resistance to animal
food products produced using biotech-
nology continues to raise uncertainty
among analysts of the food system (Kin-
sey and Senaeur; Caswell et al.). Animal
food products in particular raise concerns
because consumer surveys seem to docu-
ment less acceptance of genetic modifi-
cation of animals than of plants. Exami-
nation of the widely publicized and
analyzed introduction of recombinant
bovine somatotropin (rbST) reduces the
uncertainty over consumer demand for
animal food products produced by
biotechnology. 
BST is a bovine growth hormone that
occurs naturally in cows; rbst is bst pro-
duced by genetically altered bacteria in
the laboratory. Laboratory-produced
rbST, when injected into cows, increases
their milk production. 
Despite the uncertainty, research contin-
ues on genetic modifications of animals.
In the not-too-distant future, commer-
cially produced swine, sheep, and chick-
ens may mature more quickly thanks to
the addition of other species’ growth
genes. Cows may produce milk palatable
to lactose-intolerant people (Krimsky and
Wrubel, p. 195). 
Clues to the future of animal food prod-
ucts from biotechnology may be found in
the fervor surrounding the announcement
of rbST contrasted with the ultimate sta-
bility in the milk market. Comparing sur-
vey evidence available before the com-
mercial introduction of rbST with an
econometric analysis of milk demand
afterwards indicates that the survey evi-
dence did not accurately predict the
effects of rbST on milk demand.
The Road to rbST Approval
The technique used to develop bacteria
that grow rbST was bioengineering, the
transfer of genetic material from one
species into another or the modification
of the genetic material in a species in
order to change the characteristics of the
receiving or modified species. The result-
ing plant or animal is referred to as trans-
genic, if material was transferred, or bio-
engineered, for both modified and
transferred material. One procedure used
to transfer genetic material is also called
recombinant DNA. The basic technology
dates from the 1970’s (Krimsky and
Wrubel, p. 1).
Agriculture Information Bulletin No. 747-01 December 1998The first report on the use of rbST to
increase milk production appeared in
1982. In 1984-85, the Food and Drug
Administration (FDA) ruled that milk
and meat from rbST-treated cows in
experimental herds were safe for human
consumption and could be marketed.
Some milk and meat from rbST-treated
cows were then introduced into the food
supply and were consumed throughout
the controversy over rbST’s final
approval.
In the decade following, rbST was stud-
ied extensively. By 1993, more than
1,500 studies, books, professional papers,
and surveys examined rbST and its im-
plications. Virtually all scientific studies
determined that rbST posed no danger to
human consumption (Executive Branch).
Backed by overwhelming scientific opin-
ion that rbST was safe for human con-
sumption, FDA approved general use of
rbST in November 1993. Controversy
continued. Consumer representatives at a
May 1993 hearing sponsored by FDA
described negative consumer reaction
arising from a number of concerns,
including fear of new technology, animal
welfare, milk’s link with children, and
support of small-scale agriculture (Exec-
utive Branch).
During the decade before rbST’s com-
mercial availability, estimates of adop-
tion rates varied widely, depending on
the methodology of the study and
assumptions about costs. The estimates
ranged between 8 and 40 percent of U.S.
producers using rbST on 6 to 90 percent
of cows (Caswell et al.), because produc-
ers’ decision to use rbST is complicated.
Use of rbST can increase producer
income from milk in excess of the cost
of rbST applications. To increase produc-
tion, however, producers must properly
time rbST applications and adjust feed
supplies to meet the cow’s increasing
nutrition requirements for added milk
production. U.S. Department of Agricul-
ture (USDA) expectations before FDA
approval were for treatment of approxi-
mately 30 percent of cows by 1998.
(Although estimates of rbST adoption as
of early 1998 vary widely, probably 12
to 18 percent of cows are actually now
treated with rbST.)
In response to consumer concern, Con-
gress voted for a moratorium on rbST
until February 1994. Public concern over
rbST was strong despite a library of sci-
entific evidence of its safety. Clearly, a
conclusive body of scientific study con-
firming safety is insufficient to counter
consumer concerns and prevent public
controversy over future animal food
products from biotechnology.
Surveys Attempted To Gauge
Consumer Response
Consumer surveys taken in the years just
before rbST approval documented con-
sumer concern about the use of rbST as
well as consumers’ expressed intentions
to reduce milk consumption if the prod-
uct were approved. A widely cited study
is Hoban and Kendall, a national tele-
phone survey of 1,200 consumers con-
ducted in early 1992.
The survey included questions about tra-
ditional cross-breeding, described as a
way of moving genes between the same
kind of plants or animals, and biotech-
nology, described as a way of moving
genes between different kinds of plants
or animals. A little more than half of the
respondents were aware of cross-breed-
ing; fewer were aware of biotechnology.
Questions followed about the acceptabil-
ity of cross-breeding and biotechnology.
Fewer than half accepted biotechnology
for leaner meat, increased milk produc-
tion, food flavorings, or larger sport fish.
Yet, more accepted biotechnology to
increase milk production (rbST) than
accepted traditional animal breeding.
Respondents were also questioned about
specific types of genetic transfer between
species. While 66 percent judged plant-
to-plant transfers acceptable, only 39
percent found animal-to-animal transfers
acceptable. Only 10 percent rated
human-to-animal transfers acceptable.
These results could forewarn of contro-
versy over food products from transgenic
animals based on moral issues.
Finally, a question rated confidence in
government agencies’ ability  to regulate
biotechnology effectively. USDA re-
ceived the highest marks: over 80 per-
cent had some or a lot of confidence in
its ability. Slightly smaller proportions
had the same confidence in the Environ-
mental Production Agency (EPA) and
FDA.
Others besides Hoban and Kendall have
found consumer disapproval of tradi-
tional cross-breeding. In a survey of New
Jersey consumers, Hallman found that
two-thirds of respondents disapproved of
hybrid animals and half found them
“morally wrong.”  He  also cited similar
responses from an Office of Technology
Assessment survey.
Clearly, the finding that consumers dis-
approve of traditional cross-breeding
does not translate into refusal to purchase
milk and meat from common farm ani-
mals, such as cows and pigs, which have
been cross-bred for many years. More
likely, it indicates a separation of con-
sumer attitudes about plants and animals
from attitudes about food due to a blur-
ring of the link between production agri-
culture and food purchased by consumers.
In 1992, Smith and Warland summarized
11 consumer studies, including the
Hoban and Kendall study. Averaging
over all the studies, Smith and Warland
concluded that  57 percent of respon-
dents viewed rbST negatively. Smith and
Warland noted an important caveat to all
the survey results—the largely negative
response was consistent with research
findings that respondents with limited
understanding of a situation in which
they perceive some risk are more likely
to focus on negative characteristics and
information.
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Clues to the future of 
animal food products from 
biotechnology may be found 
in the fervor surrounding 
the announcement of 
rbST contrasted with the 
ultimate stability in the 
milk market.Based on the responses to multiple con-
sumer surveys, analysts expected that
farmers’ use of rbST would trigger a 4-
to 20-percent decline in consumption of
fluid milk (Executive Branch).
Consumer Demand After
rbST: Almost No Effect  
When rbST was approved, survey evi-
dence had created expectations of at least
a temporary reduction in milk consump-
tion. To determine whether the surveys
had accurately predicted the future, tests
on the effect of rbST on milk consump-
tion were conducted using a model of
fluid milk consumption originally devel-
oped to estimate the effect of generic
fluid milk advertising  (Blisard, Blaylock,
and Smallwood). This model could
gauge whether rbST had a negative
effect that was offset by positive effects
from other factors. The model, a single
equation, uses average per capita con-
sumption of fluid milk as the dependent
variable and independent variables
including advertising, time, season, price
per half gallon of milk and average per
capita income (both adjusted for infla-
tion), and a series of demographic vari-
ables.  The model is estimated using
pooled time series and regional data:
monthly data from December 1978 to
September 1996 for 12 selected milk
marketing orders, representing about 43
percent of milk sales in the United
States.
Several hypotheses were tested (table 1).
These tests found no effect of the intro-
duction of rbST on aggregate fluid milk
consumption.1
Before the introduction of rbST, some
large supermarket chains announced that
they would not sell milk from rbST-
treated cows. Milk cooperatives (the
wholesalers between producers and
supermarkets) serving these chains
allowed producers to self-certify that
they did not use rbST. Some suppliers
did label milk products, but the labeled
products’ share of the market was small.
One Northeast chain of about 50 stores
reported the market share of labeled
rbST-free milk in its stores at 1.5 percent
in the first year after FDA approval.
However, most fluid milk was unlabeled
so there were few (if any) visual remin-
ders about rbST at the point of purchase.
To examine changes in the market after
the introduction of rbST, test 4, a test for
a possible change in market structure, is
the most meaningful because it simulta-
neously compared the intercept, slope,
and coefficients on price, income, and
other variables before and after the intro-
duction of rbST. That none of these coef-
ficients changed is consistent with little
change in consumer purchases due to the
presence of rbST in the market. Signifi-
cant shifts within the market among gro-
cery chains or between labeled and unla-
beled milk most likely would not have
left demographic, price, and income
coefficients unchanged, particularly
because labeled rbST-free milk generally
cost more.
Other econometric results show no or
minimal effects of rbST on milk demand.
Kaiser found significant but very small
negative effects on retail demand for fluid
milk and cheese but positive, and large,
effects on butter and frozen desserts. The
positive effects on butter and frozen
desserts raise the possibility that his
rbST dummies might reflect some other
interactions among variables. ERS runs
of a modified version of Kaiser’s model
have not found significant effects of
rbST on fluid milk demand.
Whether this apparent absence of rbST
impact in the retail milk market occurred
because consumers essentially trusted
government regulation, were unaware of
the introduction of rbST, or were not
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Econometric tests found 
no effect of the 
introduction of rbST on 
aggregate fluid milk
consumption.
Table 1. Hypotheses and tests of consumer reaction to rbST
Variable changes in model runs Hypothesis tested
1. rbST dummies for intercept, price, and income The actual sale of rbST caused consumers to
variables from February 1994 to September 1996. reduce fluid milk consumption.
2. rbST dummies from November 1993 The announced approval caused a temporary,
to October 1994. 1-year reduction in consumption that disappeared
over time due to experience of no negative effects.
3. rbST dummies from November 1993 An “announcement” effect of the approval and
through February 1994. Congressional action temporarily reduced consumption.
4. Sample divided in two parts before  The introduction of rbST changed the structure
and after February 1994—no explicit  of the fluid milk market.
rbST dummies.
1 In all cases, F tests of the regressions
described below, compared with the original
model, were insignificant.willing to incur the cost of making
adjustments is uncertain. Habit and con-
venience (low transaction costs) are
important determinants of food buying.
Why Little or No Effect? 
Theories of Consumer
Behavior
In modern economic theory, information
is costly to both the consumer and the
producer; benefits must outweigh costs
for its use or production. Beginning in
1961 with Stigler, who focused on price
information, economists have been
incorporating information into consumer
demand theory.
Kevin Lancaster and Sherwin Rosen pio-
neered the consideration of goods as
bundles of characteristics that could
change with technology and innovation
(Ratchford; Agarwal and Ratchford).
Soon this characteristics approach was
combined with Stigler’s cost-of-informa-
tion approach  (Lynch and Schuler; Nel-
son; Darby and Karni) to form the eco-
nomics of information theory (EOI).
The EOI literature distinguishes among
search, experience, and credence charac-
teristics. The consumer acquires informa-
tion in each category differently, incur-
ring different costs. Search characteris-
tics include product cost, size of pack-
age, color, measurements of the product,
and locations of sale. These characteris-
tics can be determined prior to making
the purchase, with some time costs of
search. Experience characteristics, such
as taste and durability, can be determined
by consumption, or possibly through the
testimony of friends and other sources,
also at a time cost.  Credence character-
istics cover those that can never be deter-
mined directly by the consumer, even
after consumption, such as nutrition of a
food, expertise of a professional, and
honesty of a repairman. Consumers may
seek information on all three characteris-
tics; sellers will try to provide such in-
formation through advertising, reputa-
tion, and other means. Third parties such
as governments, professional associa-
tions, and consumer reporting services
will also provide information, again with
costs.
The most relevant question, based on
EOI,  is what milk characteristics con-
sumers are actively considering in the
decision to buy milk from rbST-treated
cows. Surveys on consumer response to
labels revealed that both possibilities for
labeling—milk labeled either as from
cows treated with rbST or not treated
with rbST—created a perception of “dif-
ference” between the labeled milk and
other milk. Most respondents who per-
ceived a difference mentioned safety and
contamination as potential differences
(Westgate Research, Inc., 1993a, 1993b,
1994a, 1994b), indicating food safety
concerns.
EOI offers an interesting interpretation
of the consumer reaction to rbST. If the
consumer concern over rbST involved
mainly a food safety issue, it was a cre-
dence characteristic at the individual
level. To evaluate the credence claim of
safety, the consumer could either trust
government regulation, at no cost, or
research the rbST issue, at considerable
cost in time. From this perspective,
charging government agencies with the
responsibility saves the costs of deter-
mining safety for the rest of society
(Kuchler et al.). 
Society as a whole experiences food
safety issues differently than individuals
do.  If the whole milk supply, or food
supply in general, is unacceptably risky,
the incidence of disease will increase and
become publicly known. Media reports
on foodborne illness outbreaks, and their
absence, are an important source of
information to the consumer. Thus, EOI
provides an explanation of the uninter-
rupted consumption of fluid milk after
commercial availability of rbST. As a
whole, consumers did not hear of nega-
tive experiences from milk consumption,
and may have been comfortable relying




RbST is an animal drug and was regu-
lated as such by the FDA. Even though
the regulatory process for animal drugs
is different from that for foods, the
result—unlabeled milk from rbST-treated
cows—offers insight into consumer
acceptance of future animal food prod-
ucts from biotechnology. Because milk
from rbST-treated cows was determined
to be safe and was not different from
other milk, no special handling or label-
ing was required. (Milk from untreated
cows could be so labeled.)  In practice,
most milk from treated cows cannot be
identified by consumers. Unfamiliar
terms on labels could have caused uncer-
tainty and concerns over risk, as the
Westgate surveys revealed.
The guiding principle of Federal regula-
tion of food products from biotechnology
is that the product, not the process of
production, is regulated (Caswell et al.).
Thus, products produced by biotechnol-
ogy are judged by the same standards of
protection of public health and safety as
are other products. In 1998, continued
use of the product principle may be
smoothing the transition of a number of
bioengineered plants into the food sup-
ply. Whether or not the principle will
ease adoption of bioengineered animals
into the food supply remains to be seen.
FDA regulates most food products (meat
and poultry are regulated by USDA) and
animal feed and drugs. FDA description
of its approach to bioengineered plant
food products reads in part:  
Based on our present knowledge
of developments in agricultural
research, we believe that most of
the substances being introduced
into food by genetic modifica-
tion have been safely consumed
as food or are substantially simi-
lar to such substances. There-
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The guiding principle of 
Federal regulation of
biotechnology is that 
the product, not the 
process of production, 
is regulated.fore, we do not anticipate that
most foods developed by recom-
binant DNA methods will con-
tain substances that require pre-
market approval as new food
additives (FDA, 1995).
FDA has issued guidelines to the food
industry on the circumstances in which
consultation with FDA is recommended
before marketing a bioengineered food
product (Kessler et al.).
FDA does not require special labeling of
a biotechnology-produced food solely on
the basis of the process. FDA requires
labeling of plant foods from biotechnol-
ogy only when the food has been signifi-
cantly altered from the traditional food.
An example would be soybean oil with
higher than naturally occurring levels of
oleic acid that must be labeled “high
oleic soybean oil” rather than simply
“soybean oil.”
When genetically modified meat and
poultry enter commercial channels, they
will be regulated by the Food Safety and
Inspection Service (FSIS) of the U.S.
Department of Agriculture, whose policy
on labeling of products from biotechnol-
ogy is consistent with FDA’s.
Conclusion
Four major lessons from the rbST expe-
rience offer future insight for animal
food products produced with biotechnol-
ogy:
1. Scientific evidence about food safety
will not prevent controversy. As long as
some consumers doubt the scientific evi-
dence,  biotechnological advances may
create controversy.
2. Even intense controversy may have
minimal or no effect on total consumer
demand. Consumer demand for milk was
unaffected, which suggests that other
products could be similarly unaffected.
3.  The absence of reports of harm from
consumption contributes to continued
consumption. Survey evidence indicates
that consumers perceive biotechnology
as a food safety issue and sometimes a
moral issue. In the absence of reported
harm, consumers continue purchasing
the affected product.
4. The Federal Government’s regulation
contributes to continuing consumption.
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